ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Live Kidney Donor Study

This study is ongoing, but not recruiting participants.

Sponsors and Collaborators: National Institute of Allergy and Infectious Diseases (NIAID)
National Heart, Lung, and Blood Institute (NHLBI)
Health Resources and Services Administration (HRSA)
Information provided by: National Institute of Allergy and Infectious Diseases (NIAID)
ClinicalTrials.gov Identifier: NCT00608283
  Purpose

Kidney transplants from living donors now account for 40% of all the kidney transplants done in the United States. However, the current information on how donating a kidney can affect the donor's long term health needs further investigation. The purpose of this study is to collect data on a large number of live kidney donors and create and analyze a comprehensive database. Information about the number of living kidney donors, including those who have experienced kidney failure, heart problems, and death will be gathered for the database. Investigators will then use the database to identify the risks of kidney failure, associated conditions, and death after living donation. The database will also be used to identify characteristics that put donors at higher risk for health problems after donation.


Condition Intervention
Kidney Transplantation
End Stage Renal Disease
Other: Record Review

MedlinePlus related topics:   Kidney Failure    Kidney Transplantation   

U.S. FDA Resources

Study Type:   Observational
Study Design:   Cohort, Prospective
Official Title:   Live Kidney Donor Study

Further study details as provided by National Institute of Allergy and Infectious Diseases (NIAID):

Primary Outcome Measures:
  • Overall mortality [ Time Frame: Throughout study ] [ Designated as safety issue: Yes ]
  • Cause-specific mortality [ Time Frame: Throughout study ] [ Designated as safety issue: Yes ]
  • end stage renal disease as defined in the protocol [ Time Frame: Throughout study ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • Cardiovascular and renal morbidity [ Time Frame: Throughout study ] [ Designated as safety issue: Yes ]
  • 6 months incidence of adverse events [ Time Frame: At 6 months after kidney donation ] [ Designated as safety issue: Yes ]

Biospecimen Retention:   Samples With DNA

Biospecimen Description:

blood samples


Estimated Enrollment:   8466
Study Start Date:   August 2007
Estimated Study Completion Date:   June 2011
Estimated Primary Completion Date:   June 2011 (Final data collection date for primary outcome measure)

Groups/Cohorts Assigned Interventions
1
People who are going to donate a kidney at one of the three transplant centers from August 2007 until Jume 2011
Other: Record Review
This study entails a retrospective review of records. There is no study intervention.

Detailed Description:

Kidney transplantation is the preferred treatment to dialysis for most people with kidney failure. However, the current waiting time to receive a kidney from a deceased donor is greater than 5 years in some parts of the United States. Kidneys from living donors have increased the number of kidneys available for transplantation and decreased the waiting period for those needing a transplant. Living kidney donation also provides several advantages over deceased donor kidneys, including more timely transplantation and longer function of the transplanted kidney. Despite these facts, there is inadequate information about whether living kidney donation may have serious adverse effects on the donor's health. Long-term data on the health risks of living donation are needed.

The purpose of this study is to establish and analyze a database of information on living donors who have or are going to donate a kidney at three transplant centers with longstanding live kidney donation programs through June 2011. Donor and recipient characteristics as well as specific data on kidney failure, heart disease, and death will be collected. National databases such as the Scientific Registry of Transplant Recipients, the Social Security Death Master File, the National Death Index and records maintained by the Centers for Medicare and Medicaid Services for patients with end stage renal disease (ESRD) will be used to supplement data provided by the participating transplant centers. After establishing the database, researchers expect to 1) determine the long-term risk of live kidney donation and 2) identify donor characteristics associated with higher risk for health problems after donation. Death, cause of death, and incidence of ESRD will be compared to those rates reported by the Centers for Disease Control and Prevention for the U.S. population during the same time period.

There will be no study visits for this study. Investigators will gather data from the medical charts of all live kidney donors from the three transplant centers through June 2011.

  Eligibility
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample

Study Population

People who will donate kidneys at one of the three transplant centers between August 2007 and June 2011


Criteria

Inclusion Criteria:

  • Donated kidney at one of the three participating study centers

Exclusion Criteria:

  • None
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00608283

Locations
United States, Alabama
University of Alabama at Birmingham    
      Birmingham, Alabama, United States, 35294
United States, Minnesota
Mayo Clinic    
      Rochester, Minnesota, United States, 55905
University of Minnesota    
      Minneapolis, Minnesota, United States, 55455

Sponsors and Collaborators

Investigators
Principal Investigator:     Sandra J. Taler, MD     Division of Nephrology and Hypertension, Mayo Clinic    
Principal Investigator:     Clifton Kew, MD     University of Alabama at Birmingham    
Principal Investigator:     Hassan Ibrahim, MD     University of Minnesota    
  More Information


Publications:

Responsible Party:   DAIT/NIAID ( Associate Director, Clinical Research Program )
Study ID Numbers:   DAIT RELIVE-01
First Received:   February 5, 2008
Last Updated:   September 26, 2008
ClinicalTrials.gov Identifier:   NCT00608283
Health Authority:   United States: Federal Government

Keywords provided by National Institute of Allergy and Infectious Diseases (NIAID):
Kidney transplant  
Live donor transplant  

Study placed in the following topic categories:
Renal Insufficiency
Urologic Diseases
Renal Insufficiency, Chronic
Kidney Failure, Chronic
Kidney Diseases
Kidney Failure

ClinicalTrials.gov processed this record on November 03, 2008




Links to all studies - primarily for crawlers